Literature DB >> 21165602

Medical costs of osteoporosis in the elderly Medicare population.

S W Blume1, J R Curtis.   

Abstract

UNLABELLED: Prior national cost estimates of osteoporosis and fractures in the USA have been based on diverse sets of provider data or selected commercial insurance claims. Based on a random population-based sample of older adults, the US medical cost of osteoporosis and fractures is estimated at $22 billion in 2008.
INTRODUCTION: National cost estimates of osteoporosis and fractures in the USA have been based on diverse sets of provider data or selected commercial insurance claims. We sought to characterize prevalence and costs for osteoporosis using a random population-based sample of older adults.
METHODS: A cross-sectional estimate of medical cost was made with 2002 data from the Medicare Current Beneficiary Survey (MCBS). MCBS combines health interviews with claims information from all payers to profile a random sample of 12,700 Medicare recipients. Three cohorts aged 65 or over were defined: (1) patients experiencing a fracture-related claim in 2002; (2) patients with a diagnosis, medication, or self-report for osteoporosis or past hip fracture; and (3) non-case controls. The total cost of patient claims was compared to that of controls using multiple regression.
RESULTS: Of 30.2 million elderly Medicare recipients in 2002, 1.6 million (5%) were treated for a fracture that year, and an additional 7.2 million (24%) have osteoporosis without a fracture. The estimated mean impact of fractures on annual medical cost was $8,600 (95% confidence interval, $6,400 to $10,800), implying a US cost of $14 billion ($10 to $17 billion). Half of the non-fracture osteoporosis patients received drug treatment, averaging $500 per treated patient, or $2 billion nationwide.
CONCLUSIONS: The annual cost of osteoporosis and fractures in the US elderly was estimated at $16 billion, using a national 2002 population-based sample. This amount corroborates previous estimates based on substantially different methodologies. Projected to 2008, the national cost of osteoporosis and fractures was $22 billion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21165602      PMCID: PMC3767374          DOI: 10.1007/s00198-010-1419-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  20 in total

1.  Survival experience of aged hip fracture patients.

Authors:  J Magaziner; E M Simonsick; T M Kashner; J R Hebel; J E Kenzora
Journal:  Am J Public Health       Date:  1989-03       Impact factor: 9.308

2.  Race and sex differences in mortality following fracture of the hip.

Authors:  S J Jacobsen; J Goldberg; T P Miles; J A Brody; W Stiers; A A Rimm
Journal:  Am J Public Health       Date:  1992-08       Impact factor: 9.308

3.  Healthcare use among U.S. women aged 45 and older: total costs and costs for selected postmenopausal health risks.

Authors:  T J Hoerger; K E Downs; M C Lakshmanan; R C Lindrooth; L Plouffe; B Wendling; S L West; R L Ohsfeldt
Journal:  J Womens Health Gend Based Med       Date:  1999-10

4.  Hip fracture incidence and mortality in New England.

Authors:  E S Fisher; J A Baron; D J Malenka; J A Barrett; W D Kniffin; F S Whaley; T A Bubolz
Journal:  Epidemiology       Date:  1991-03       Impact factor: 4.822

5.  Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group.

Authors:  B Ettinger; D M Black; M C Nevitt; A C Rundle; J A Cauley; S R Cummings; H K Genant
Journal:  J Bone Miner Res       Date:  1992-04       Impact factor: 6.741

6.  Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.

Authors:  N F Ray; J K Chan; M Thamer; L J Melton
Journal:  J Bone Miner Res       Date:  1997-01       Impact factor: 6.741

7.  Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III.

Authors:  Anne C Looker; L Joseph Melton; Tamara B Harris; Lori G Borrud; John A Shepherd
Journal:  J Bone Miner Res       Date:  2010-01       Impact factor: 6.741

8.  The cost of treating osteoporosis in a managed health care organization.

Authors:  Shetal S Desai; Babette S Duncan; Alice S Sloan
Journal:  J Manag Care Pharm       Date:  2003 Mar-Apr

9.  Evaluation of adverse health outcomes associated with vertebral fractures.

Authors:  P D Ross; B Ettinger; J W Davis; L J Melton; R D Wasnich
Journal:  Osteoporos Int       Date:  1991-06       Impact factor: 4.507

10.  Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: the Chingford Study.

Authors:  T D Spector; E V McCloskey; D V Doyle; J A Kanis
Journal:  J Bone Miner Res       Date:  1993-07       Impact factor: 6.741

View more
  82 in total

1.  Oral contraceptive use and fracture risk around the menopausal transition.

Authors:  Delia Scholes; Andrea Z LaCroix; Rebecca A Hubbard; Laura E Ichikawa; Leslie Spangler; Belinda H Operskalski; Nancy Gell; Susan M Ott
Journal:  Menopause       Date:  2016-02       Impact factor: 2.953

2.  The Fracture Liaison Service to close the osteoporosis care gap: a leadership educational model for undergraduate and postgraduate trainees.

Authors:  Micah Yu; Christina Downey; Karina D Torralba
Journal:  Clin Rheumatol       Date:  2019-11-23       Impact factor: 2.980

3.  A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk.

Authors:  S Nayak; S L Greenspan
Journal:  Osteoporos Int       Date:  2019-01-08       Impact factor: 4.507

Review 4.  Genetics of aging bone.

Authors:  Douglas J Adams; David W Rowe; Cheryl L Ackert-Bicknell
Journal:  Mamm Genome       Date:  2016-06-06       Impact factor: 2.957

5.  Peripheral blood monocyte-expressed ANXA2 gene is involved in pathogenesis of osteoporosis in humans.

Authors:  Fei-Yan Deng; Shu-Feng Lei; Yan Zhang; Yu-Ling Zhang; Yan-Peng Zheng; Li-Shu Zhang; Rong Pan; Lili Wang; Qing Tian; Hui Shen; Ming Zhao; Yunxia Wang Lundberg; Yao-Zhong Liu; Christopher J Papasian; Hong-Wen Deng
Journal:  Mol Cell Proteomics       Date:  2011-08-04       Impact factor: 5.911

6.  Comparison of interactive voice response, patient mailing, and mailed registry to encourage screening for osteoporosis: a randomized controlled trial.

Authors:  L Heyworth; K Kleinman; S Oddleifson; L Bernstein; J Frampton; M Lehrer; K Salvato; T W Weiss; S R Simon; M Connelly
Journal:  Osteoporos Int       Date:  2014-02-25       Impact factor: 4.507

7.  Middle school-aged child enjoyment of food tastings predicted interest in nutrition education on osteoporosis prevention.

Authors:  Feon W Cheng; Shannon M Monnat; Barbara Lohse
Journal:  J Sch Health       Date:  2015-07       Impact factor: 2.118

8.  Exploring Racial, Gender, and Insurance Disparities in Patients with Osteoporotic Fractures.

Authors:  Sarah C DeShields; Cynthia C Romero; Tina D Cunningham
Journal:  J Community Health       Date:  2017-12

9.  Bone mineral density in patients with mucopolysaccharidosis type III.

Authors:  Banu Guzel Nur; Hakan Nur; Ercan Mihci
Journal:  J Bone Miner Metab       Date:  2016-05-18       Impact factor: 2.626

10.  Efficacy of autologous bone marrow derived Mesenchymal stem cells (MSCs), osteoblasts and osteoblasts derived exosome in the reversal of ovariectomy (OVX) induced osteoporosis in rabbit model.

Authors:  Mir Sadat-Ali; Dakheel A Al-Dakheel; Haifa A Al-Turki; Sadananda Acharya
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.